Image

Anomalous Aortic Origin of Coronary Artery

Anomalous Aortic Origin of Coronary Artery

Recruiting
All
Phase N/A

Powered by AI

Overview

This project has several objectives ranging from clinical data analysis to computational simulations as listed below:

  1. Clinical objectives:
    1. Retrospective review of all patients with AAOCA treated surgically and followed medically at the IRCCS Policlinico San Donato aiming to identify risk factors for ischemia or sudden cardiac deaths.
    2. Prospective follow-up of all enrolled patients, treated and followed, in adjunct to all the new patients referred aiming to follow across the years any potential rare adverse event (ischemia, angina event, sudden cardiac death).
  2. Experimental objectives:
    1. Retrieve morphological measurements from CT or MRI (de-identified) of the aortic root and the coronary vessels following the previous work of our group.
    2. Construct a parametric model of the aortic root defined by population-based morphologic parameters to describe both healthy/diseased population.
    3. Run solid mechanics simulation mimicking the movement of the aortic root in order to test configurations at more risk.
    4. Reconstruct 3D surfaces representing the coronary vasculature from imaging for automatically perform the parameter estimation and run computational fluid dynamics simulations.

Eligibility

Inclusion Criteria:

  • All patients (adults and pediatrics) who have been diagnosed with an anomalous aortic origin of any of the coronary arteries (AAOCA) without any other congenital heart disease and diagnosed/referred or followed at the IRCCS Policlinico San Donato.

Exclusion Criteria:

  • Patients with other major congenital heart disease with associated coronary artery origin anomalies will be excluded.
        Patients with anomalous origin of the coronary artery from the pulmonary artery (ALCAPA or
        ARCAPA) will be excluded.
        Patients women who are pregnant.

Study details
    Anomalous Aortic Origin of the Coronary Artery (AAOCA)

NCT05692063

IRCCS Policlinico S. Donato

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.